Publications

Home > Newsroom > Publications

Wellmera regularly publishes peer-reviewed publications and poster presentations. Our publications are presented below in reverse chronological order.

• Liquid biopsies in breast cancer early detection, metastatic progression and therapy success: Opportunities and challenges for the patients, providers and payers

  Authors: Obradovic M, Fonseca AF, Ricci JF, André C
  Wellmera AG, Basel, Switzerland

  Poster Presented at ISPOR Barcelona 2018.

  

• Use of pCR as a surrogate primary endpoint in drug pivotal trials in neoadjuvant early breast cancer in the EU: A Perspective from Regulators and Payers

  Authors: Fonseca AF, Deplazes SN,
  Wellmera AG, Basel Switzerland

  Poster Presented at ISPOR Barcelona 2018.

  

• A Gap Analysis Between The International Consortium For Health Outcomes Measurement Heart Failure Standard Set And A Global Selection Of Real-World Data Sources

  Authors: De la Torre A, Justo N, Proenca C, Arora J, Castelo Branco A, Rajpura J, Calado F.
  ICHOM White paper
  Year: 2017

• Hospitalisations among a cohort of patients with heart failure versus an age- and sex-matched cohort without heart failure in england: a comparative study using CPRD data

  Authors: Gielen V, Calado F, Balas B, Proenca CC, Bruce Wirta S, Mcmahon P, Lucrezi g, Richards C, Croft D.
  ISPOR 20th Annual European Congress Poster PHS111 e2
  Year: 2017

• Burden of chronic heart failure on caregivers: a multinational cross-sectional survey in real world setting

  Authors: Calado F, Viriato D, Proenca CC, Lahoz R, Agrawal R, Cotton S, Jackson J
  ISPOR 20th Annual European Congress Poster PCV126 j13
  Year: 2017

• Health-related quality of life for everolimus versus placebo in patients with advanced, non-functional, well-differentiated gastrointestinal or lung neuroendocrine tumours (RADIANT-4): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.

  Pavel ME, Singh S, Strosberg JR, Bubuteishvili-Pacaud L, Degtyarev E, Neary MP, Carnaghi C, Tomasek J, Wolin E, Raderer M, Lahner H, Valle JW, Pommier R, Van Cutsem E, AUTHORS: Tesselaar MET, Fave GD, Buzzoni R, Hunger M, Eriksson J, Cella D, Ricci JF, Fazio N, Kulke MH, Yao JC.
  Lancet Oncol 2017 18(10):1411-1422
  YEAR: 2017

• Burden of disease on chronic heart failure patients: a multinational cross-sectional survey in real world setting

  Authors: Viriato D, Proenca CC, Lahoz R, Agrawal R, Cotton S, Jackson J, Calado F
  ISPOR 20th Annual European Congress Poster PCV127 j14
  Year: 2017

• Patient characteristics and treatment patterns in chronic heart failure: results from a multinational real-world cross sectional survey

  Authors: Proenca CC, Viriato D, Lahoz R, Agrawal R, Cotton S, Jackson J, Calado F
  ISPOR 20th Annual European Congress Poster PCV169 k21
  Year: 2017

• Assessing the burden of chronic heart failure on caregivers of patients in colombia

  Authors: Karpf E, Jackson J, Cotton S, Proenca C, Calado F, Barbeau M, Macpherson A
  ISPOR 20th Annual European Congress Poster PCV119 j6
  Year: 2017

• Assessing the burden of chronic heart failure on patients in colombia

  Authors: Karpf E, Jackson J, Cotton S, Calado F, Proenca C, Barbeau M, Macpherson A
  ISPOR 20th Annual European Congress Poster PCV123 j10
  Year: 2017

• Cost-effectiveness of everolimus plus reduced tacrolimus in de novo liver-recipients in the italian setting

  Authors: Bianic F, Campbell R, Damera V, De simone P, Roccia A, Gegson J, Ricci JF
  Journal Of Medical Economics 2016 19 (9):866-73
  Year: 2016

• Patterns of resource utilization and cost for postmenopausal women with hormone receptor–positive, human epidermal growth factor receptor-2–negative advanced breast cancer in europe

  Authors: Jerusalem G, Neven P, Marinsek N, Zhang J, Degun R, Benelli G, Saletan S, Ricci JF, Andre F
  BioMed Central Cancer 2015 15:787
  YEAR: 2015

• Health-related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO-2 trial.

  AUTHORS: Burris HA, Lebrun F, Rugo HS, Beck JT, Piccart M, Neven P, Baselga J, Petrakova K, Hortobagyi GN, Komorowski A, Chouinard E, Young R, Gnant M, Pritchard KI, Bennett L, Ricci JF, Bauly H, Taran T, Sahmoud T, Noguchi S.
  Cancer 2013 119(10):1908-15
  YEAR: 2013